2013 Italy Tumor Marker Testing Market: Opportunities andStrategies for SupplierReport Details:Published:December 2012No. ...
A. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer4. Prostate Cancer5. Stomach Cance...
PNP5-Nucleotidase27. OncogenesAbl/abl-bcrAIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP-17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSi...
Interleukin-1 (IL-1)Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor MarkersN-Acetylglucosamin...
Human Carcinoma AntigenHPAHSP27Intermediate FilamentsCytokeratins/CK18/Cyfra 21-1DesminGliofibrillary Acid ProteinNeurofil...
SN10SomatostatinTA-90TABATachykininTAG 12TPSTroponinTubulinVCAMVEGFVillenC. Instrumentation Review AndMarket Needs1. Abbot...
29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emergi...
d. Malignant LymphomasLymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocati...
C. Competition D. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing ...
PolymedcoPreMDQiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara BioTargeted Diagnostics & Therape...
Oncogenes Potential Applications In Cancer DiagnosisMajor Companies Developing or Marketing Oncogene TestsGrowth Factors P...
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Parathyroid Hormone Test Volume and Di...
Upcoming SlideShare
Loading in...5
×

2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Supplier

64

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
64
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Supplier

  1. 1. 2013 Italy Tumor Marker Testing Market: Opportunities andStrategies for SupplierReport Details:Published:December 2012No. of Pages: 570Price: Single User License – US$5400Highlights•Comprehensive 570-page analysis of the Italian tumor marker testing market.•Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.•Ten-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories.•Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.•Current instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Get your copy of this report @http://www.reportsnreports.com/reports/213053-2013-italy-tumor-marker-testing-market-opportunities-and-strategies-for-supplier.htmlMajor points covered in Table of Contents of this report includeTable of ContentsIntroductionWorldwide Market and Technology Overview
  2. 2. A. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer12. Bladder CancerB. Major Current And Emerging Cancer Diagnostic Tests1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor MarkersADAB-Protein
  3. 3. PNP5-Nucleotidase27. OncogenesAbl/abl-bcrAIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP-17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSisSrc28. Polypeptide Growth FactorsBasic Fibroblast Growth FactorBeta-TGFCachectin (TNT)CalmodulinECFRNerve Growth Factor (NGF)Epidermal Growth Factor (EGF)Ornithine DecarboxylaseTransferrinTransforming Growth Factor-Alpha29. Ectopic Hormones30. Colony Stimulating Factors31. LymphokinesAlpha-InterferonB Cell Growth FactorsB Cell Growth Factor (BCGF)Gamma-Interferon
  4. 4. Interleukin-1 (IL-1)Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor MarkersN-AcetylglucosamineActinAlpha-ActinAntineuronal Antibodies7B2B72.3BaxBCD-F9BLCA-4Blood Group Antigens A,B,HCA 50CA 72-4/TAG-72CA 195CA-242CA-549CAM 26CAR-3Cathepsin-DChromogranin A and BCluster 1 AntigenCluster-5/5A AntigenCTACU18DR-70DU-PAN-2Endometrial Bleeding Associated FactorEndostatinEpithelial Membrane AntigenFeulgen HydrolysisFibronectinFSH(1->3)-L-fucosyltransferaseGastrin-Releasing Peptide (GRP)GDCFP-15GlucagonGlycoaminesH23Her-2
  5. 5. Human Carcinoma AntigenHPAHSP27Intermediate FilamentsCytokeratins/CK18/Cyfra 21-1DesminGliofibrillary Acid ProteinNeurofilamentsVimentinKA 93KinasesKP16D3LAILeukocyte Common AntigenLewis AntigensLysophosphatidic Acid (LPA)Ma 695/Ma 552MABDF3MAGME1MinactivinMN/CA9MSAMucin Cancer Antigen (MCA)Multiple Tumor Suppressor 1MyosinNEA-130NMP22OA-519Opiod PeptidesP-glycoproteinPancreatic Oncofetal Antigen (POA)Placental LactogenPR92Proliferative Index, Ki-67PxRB Inactivation/DeletionRetSCCL 175SelectinSialic AcidSialyl SSEA-1/SLX
  6. 6. SN10SomatostatinTA-90TABATachykininTAG 12TPSTroponinTubulinVCAMVEGFVillenC. Instrumentation Review AndMarket Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite
  7. 7. 29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)OverviewELISAImmunofiltrationParticle-Membrane Capture ImmunoassayEnzyme Amplificationd. Fluorescent Immunoassayse. LuminescenceChemiluminescenceBioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification MethodsPCRDAP-PCRImmuno-PCRQC-PCRCARDNAHPALCRNASBAQBRSDA3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)
  8. 8. d. Malignant LymphomasLymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyE. Personal TestingItalyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. Reagent Kits and Test Systems/PanelsB. InstrumentationC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorPotential Market Entry Barriers and RisksA. Market MaturityB. Cost Containment
  9. 9. C. Competition D. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive ProfilesAbbottAdnaGenApplied Gene TechnologiesArcaBeckman Coulter/DanaherBecton DickinsonBiomedical DiagnosticsbioMerieuxBio-RadCepheidCorrelogic SystemsDakoDecodeDiadexusDiagnocureDiasorinEiken ChemicalEnterixEnzo BiochemEpigenomicsExact SciencesFujirebioGen-ProbeGuided TherapeuticsHologicIpsogenKreatechKyowa MedexLife TechnologiesMackay Life SciencesMyriad GeneticsNanogen ElitechOncoLabOtho-Clinical DiagnosticsPanacea PharmaceuticalsPolartechnics
  10. 10. PolymedcoPreMDQiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara BioTargeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaAppendixesAppendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technologyand ApplicationsAppendix II: Assumed Currency Exchange RatesList of TablesTumor Marker ClassificationMajor Companies Developing or Marketing ACTH TestsMajor Companies Developing or Marketing AFP TestsMajor Companies Developing or Marketing Beta-2 Microglobulin TestsMajor Companies Developing or Marketing CA 15-3/27.29 TestsMajor Companies Developing or Marketing CA 19-9 TestsMajor Companies Developing or Marketing CA 125 TestsMajor Companies Developing or Marketing Calcitonin TestsMajor Companies Developing or Marketing CEA TestsMajor Companies Developing or Marketing Estrogen Receptor TestsMajor Companies Developing or Marketing Progesterone Receptor TestsMajor Companies Developing or Marketing Ferritin TestsMajor Companies Developing or Marketing Gastrin TestsMajor Companies Developing or Marketing HCG TestsMajor Companies Developing or Marketing Insulin TestsMajor Companies Developing or Marketing NSE TestsMajor Companies Developing or Marketing Occult Blood TestsMajor Companies Developing or Marketing PAP Smear/HPV TestsMajor Companies Developing or Marketing PAP TestsMajor Companies Developing or Marketing PSA TestsMajor Companies Developing or Marketing Lymphocyte Subclassification TestsBiochemical Markers Potential Applications In Cancer Diagnosis
  11. 11. Oncogenes Potential Applications In Cancer DiagnosisMajor Companies Developing or Marketing Oncogene TestsGrowth Factors Potential Applications In Cancer DiagnosisColony Stimulating Factors Potential Applications in Cancer DiagnosisLymphokines Potential Applications In Cancer DiagnosisImmunohistochemical Stains Potential Applications in Cancer Diagnosis Executive SummaryTable: Italy, Total TumorMarker Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Estimated Cancer Death Rates Per 100,000 PopulationItaly, Laboratories Performing Tumor Marker Tests by Market SegmentItaly, Hospital Laboratories Performing Tumor Marker Tests by Bed SizeItaly, Commercial/Private Laboratories Performing Tumor Markers by Annual Test VolumeItaly, Total Tumor Marker Test Volume Forecast by Market SegmentItaly, All Market Segments Major Cancer Diagnostic Test Volume ForecastItaly, Hospital Laboratories Major Tumor Marker Test Volume ForecastItaly, Commercial/Private Laboratories Major Tumor Marker Test Volume ForecastItaly, Total Tumor Marker Test Market Forecast by Market SegmentItaly, All Market Segments Major Tumor Marker Sales Forecast by TestItaly, Hospital Laboratories Major Tumor Marker Forecast by TestItaly, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by TestItaly, ACTH Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, AFP Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market SegmentItaly, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, CA 125 Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Calcitonin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, CEA Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Chromogranin Test Volume And Diagnostics Sales Forecast by Market SegmentItaly, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market SegmentItaly, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Ferritin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Gastrin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, HCG Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Insulin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market SegmentItaly, NSE Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Occult Blood Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Oncogenes Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by MarketSegment
  12. 12. Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, PAP Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, PSA Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, S-100 Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Serotonin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by MarketSegmentItaly, TDT Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, TPA Test Volume and Diagnostics Sales Forecast by Market SegmentItaly, Total Tumor Markers Sales by Major SuppliersItaly, AFP Testing Market Diagnostics Sales by Major SupplierItaly, CEA Testing Market Diagnostics Sales by Major SupplierItaly, PSA Testing Market Diagnostics Sales by Major SupplierContact: sales@reportsandreports.com for more information.

×